19617612

Source:http://linkedlifedata.com/resource/pubmed/id/19617612

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006141, umls-concept:C0006826, umls-concept:C0013216, umls-concept:C0030231, umls-concept:C0038952, umls-concept:C0040223, umls-concept:C0332293, umls-concept:C0333348, umls-concept:C0929301, umls-concept:C1280551
pubmed:issue	3
pubmed:dateCreated	2009-7-20
pubmed:abstractText	Seven of 30 female dogs diagnosed with inflammatory mammary cancer were given chemotherapy and palliative treatment, and the other 23 received only palliative treatment. The median survival time of the seven dogs given chemotherapy was 57 days, compared with 35 days for the 23 given only palliative treatment.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19617612-19717839
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0031164
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0042-4900
pubmed:author	pubmed-author:ClementeMM, pubmed-author:De AndrésP JPJ, pubmed-author:Pérez-AlenzaM DMD, pubmed-author:PeñaLL
pubmed:issnType	Print
pubmed:day	18
pubmed:volume	165
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	78-81
pubmed:meshHeading	pubmed-meshheading:19617612-Animals, pubmed-meshheading:19617612-Anti-Bacterial Agents, pubmed-meshheading:19617612-Anti-Inflammatory Agents, pubmed-meshheading:19617612-Antineoplastic Agents, pubmed-meshheading:19617612-Breast Neoplasms, pubmed-meshheading:19617612-Dog Diseases, pubmed-meshheading:19617612-Dogs, pubmed-meshheading:19617612-Drug Therapy, Combination, pubmed-meshheading:19617612-Female, pubmed-meshheading:19617612-Inflammation, pubmed-meshheading:19617612-Mitoxantrone, pubmed-meshheading:19617612-Multivariate Analysis, pubmed-meshheading:19617612-Palliative Care, pubmed-meshheading:19617612-Pilot Projects, pubmed-meshheading:19617612-Prognosis, pubmed-meshheading:19617612-Retrospective Studies, pubmed-meshheading:19617612-Spain, pubmed-meshheading:19617612-Survival Analysis, pubmed-meshheading:19617612-Vincristine
pubmed:year	2009
pubmed:articleTitle	Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy.
pubmed:affiliation	Department of Small Animal Medicine and Surgery, Veterinary Teaching Hospital, Veterinary Faculty, Complutense University of Madrid, Avenue Puerta de Hierro, 28040 Madrid, Spain. moni_vet@hotmail.com
pubmed:publicationType	Journal Article, Comparative Study